×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IGC – igc pharma, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IGC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
07:00 pm
igc
IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025
Low
Report
IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025
12/12
07:38 am
igc
Short Sellers' Secret Talks and Alliances Emerge in Court Battle [Yahoo! Finance]
Low
Report
Short Sellers' Secret Talks and Alliances Emerge in Court Battle [Yahoo! Finance]
12/2
08:30 am
igc
IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology
Medium
Report
IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology
11/25
08:30 am
igc
IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment
Medium
Report
IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment
11/14
08:30 am
igc
IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline
Low
Report
IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline
11/6
08:30 am
igc
IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies
Medium
Report
IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies
10/17
08:30 am
igc
IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1
Low
Report
IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1
10/3
09:00 am
igc
IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge
Low
Report
IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
04:05 pm
igc
Form 10-Q IGC Pharma, Inc. For: Sep 30
Low
Report
Form 10-Q IGC Pharma, Inc. For: Sep 30
9/27
04:06 pm
igc
Form 8-K IGC Pharma, Inc. For: Sep 25
High
Report
Form 8-K IGC Pharma, Inc. For: Sep 25
9/27
04:06 pm
igc
Form 4 IGC Pharma, Inc. For: Sep 25 Filed by: Moran James P
High
Report
Form 4 IGC Pharma, Inc. For: Sep 25 Filed by: Moran James P
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
6/13
IGC to Participate in Arizona’s Industrial Hemp Program
44.2%
9/19 IGC Announces IRB Approval of its IGC-AD1 for a Phase-2 study 8.3%
3/16 Form 8-K India Globalization Capi For: Mar 13 4.2%
11/6 India Globalization Capital Quarterly Loss Per Share $0.03 [Reuters] 3.3%
10/4 IGC Opens Marketing and Research Hub in Colombia 3.1%
7/26 Lifshitz & Miller LLP Announces Investigation of Amneal Pharmaceuticals, Inc., CareDx, Inc., Casa Systems, Inc., India Globalization Capital, Inc., Just Energy Group Inc., LegacyTexas Financial Group, Inc., Maxar Technologies Inc., and Unum Group 2.5%
9/19 IGC Announces IRB Approval of its IGC-AD1 for a Phase-2 study 8.3%
3/16 Form 8-K India Globalization Capi For: Mar 13 4.2%
11/6 India Globalization Capital Quarterly Loss Per Share $0.03 [Reuters] 3.3%
10/4 IGC Opens Marketing and Research Hub in Colombia 3.1%
7/26 Lifshitz & Miller LLP Announces Investigation of Amneal Pharmaceuticals, Inc., CareDx, Inc., Casa Systems, Inc., India Globalization Capital, Inc., Just Energy Group Inc., LegacyTexas Financial Group, Inc., Maxar Technologies Inc., and Unum Group 2.5%
TOP News Decliners
2/25
Form S-8 India Globalization Capi
-11.0%
12/13 Form DEF 14A India Globalization Capi For: Jan 07 -10.1%
1/9 Form 8-K India Globalization Capi For: Jan 07 -6.6%
6/14 Form 10-K India Globalization Capi For: Mar 31 -6.3%
8/8 Q1/2020 6/30/2019 EPS -0.030 ZacksConsensus N/A ActVsEst N/A - N/A -5.8%
6/12 Robbins Arroyo LLP: India Globalization Capital, Inc. (IGC) Sued for Misleading Investors -4.5%
2/10 IGC Reports Financial Results for the Quarter Ended December 31, 2019 -4.1%
3/27 Form 8-K India Globalization Capi For: Mar 26 -3.9%
9/25 Anavex, Glovia, And India Globalization Capital: The Future Of Alzheimer's Treatments [Seeking Alpha] -2.8%
6/12 Form 4 India Globalization Capi For: Jun 11 Filed by: GOEL ROHIT -2.0%
12/13 Form DEF 14A India Globalization Capi For: Jan 07 -10.1%
1/9 Form 8-K India Globalization Capi For: Jan 07 -6.6%
6/14 Form 10-K India Globalization Capi For: Mar 31 -6.3%
8/8 Q1/2020 6/30/2019 EPS -0.030 ZacksConsensus N/A ActVsEst N/A - N/A -5.8%
6/12 Robbins Arroyo LLP: India Globalization Capital, Inc. (IGC) Sued for Misleading Investors -4.5%
2/10 IGC Reports Financial Results for the Quarter Ended December 31, 2019 -4.1%
3/27 Form 8-K India Globalization Capi For: Mar 26 -3.9%
9/25 Anavex, Glovia, And India Globalization Capital: The Future Of Alzheimer's Treatments [Seeking Alpha] -2.8%
6/12 Form 4 India Globalization Capi For: Jun 11 Filed by: GOEL ROHIT -2.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: